Thymopentin for injection

Thymopentin for injection
Product Description

Thymopentin is a synthetic pentapeptide which is the active site of the naturally occurring hormone thymopoietin with immunomodulating properties. Thymopentin enhances the production of thymic T cells and may help restore immunocompetence in immunosuppressed subjects. 【Indications】
(1) Patients with chronic hepatitis B over the age of 18. Because Thymus began to shrink after the age of 18, the cellular immune dysfunction.
(2) Various primary or secondary T-cell deficiency.
(3) Certain auto-immune diseases (such as rheumatoid arthritis, systemic lupus erythematosus, etc.).
(4) Kinds of the low cellular immune function diseases
(5) Adjuvant therapy for tumors.

Read more Show less

Hainan Zhonghe Pharmaceutical Co., Ltd.

  • CN
  • 2015
    On CPHI since
  • 1
    Certificates
  • 250 - 499
    Employees
Company types
Generics/Biosimilars Manufacturer
Manufacturer/Innovator
Pharmaceutical company
Primary activities
Pharmaceutical Company (generic finished products)
View company profile
Categories
more categories Show less

Hainan Zhonghe Pharmaceutical Co., Ltd.

  • CN
  • 2015
    On CPHI since
  • 1
    Certificates
  • 250 - 499
    Employees
Company types
Generics/Biosimilars Manufacturer
Manufacturer/Innovator
Pharmaceutical company
Primary activities
Pharmaceutical Company (generic finished products)
View company profile

More Products from Hainan Zhonghe Pharmaceutical Co., Ltd. (2)

  • Atosiban Acetate Injection

    Product Atosiban Acetate Injection

    Atosiban is an inhibitor of the hormones oxytocin and vasopressin. It is used as an intravenous medication as a labour repressant to halt premature labor. Atosiban Acetate Injection is indicated to delay imm...
  • Thymalfasin for Injection

    Product Thymalfasin for Injection

    • Thymosin α1 for Injection is a purified, sterile lyophilized preparation of chemically synthesized thymosin alpha 1. It is supplied in single use vials containing 1.6 mg of lyophilized thymosin alpha 1 per vial. This drug is indicated for the treatment of chronic hepatitis B in patients 18 years of age ...